论文信息 - DREAMM-9: Phase I Study of Belantamab Mafodotin Plus Standard of Care in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma - 字舞流文

DREAMM-9: Phase I Study of Belantamab Mafodotin Plus Standard of Care in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma

S. Usmani | C. Min | B. Kremer | G. Ferron-Brady | D. Figueroa | A. Yeakey | H. Quach | I. Gupta | M. Kaisermann | Lukasz M. Mis | A. Alonso Alonso | Andreas Guenther | W. Janowski | Y. Koh | Danaè Williams | Xiaoou L. Zhou